DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

China flag China · Delayed Price · Currency is CNY
17.45
+0.39 (2.29%)
Apr 15, 2026, 3:00 PM CST
Market Cap19.87B +14.1%
Revenue (ttm)26.83B +1.1%
Net Income1.14B +33.8%
EPS1.01 +35.1%
Shares Out1.14B
PE Ratio17.25
Forward PE13.94
Dividend0.68 (3.99%)
Ex-Dividend DateNov 6, 2025
Volume6,309,869
Average Volume4,534,533
Open17.18
Previous Close17.06
Day's Range17.12 - 17.53
52-Week Range15.50 - 21.78
Beta0.64
RSI42.15
Earnings DateApr 24, 2026

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Sector Healthcare
Founded 1999
Employees 43,532
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2024, SHA:603233's revenue was 26.50 billion, an increase of 8.01% compared to the previous year's 24.53 billion. Earnings were 914.75 million, a decrease of -21.58%.

Financial Statements